Search alternatives:
ng decrease » _ decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
ng decrease » _ decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
3701
-
3702
-
3703
Image2_First-Line ICI Monotherapies for Advanced Non-small-cell Lung Cancer Patients With PD-L1 of at Least 50%: A Cost-Effectiveness Analysis.TIF
Published 2021“…</p><p>Conclusion: For advanced NSCLC patients with PD-L1 of at least 50%, cemiplimab was a cost-effective option compared with pembrolizumab and a dominant alternative against atezolizumab. …”
-
3704
Image1_First-Line ICI Monotherapies for Advanced Non-small-cell Lung Cancer Patients With PD-L1 of at Least 50%: A Cost-Effectiveness Analysis.TIFF
Published 2021“…</p><p>Conclusion: For advanced NSCLC patients with PD-L1 of at least 50%, cemiplimab was a cost-effective option compared with pembrolizumab and a dominant alternative against atezolizumab. …”
-
3705
Image3_First-Line ICI Monotherapies for Advanced Non-small-cell Lung Cancer Patients With PD-L1 of at Least 50%: A Cost-Effectiveness Analysis.TIF
Published 2021“…</p><p>Conclusion: For advanced NSCLC patients with PD-L1 of at least 50%, cemiplimab was a cost-effective option compared with pembrolizumab and a dominant alternative against atezolizumab. …”
-
3706
-
3707
Tgfβ and p53 response in the SDS pancreas.
Published 2015“…<p><b>A,</b> Steady state protein levels paralleled observed transcript changes with decreased Myc and increased p21<sup>Cip</sup> and Tgfβ expression, along with changes in Smad2 and Smad3 phosphorylation status in mutants. …”
-
3708
-
3709
Decreased <i>Pax2</i> expression in <i>p53<sup>−/−</sup></i> embryonic kidneys.
Published 2012“…<b>B</b>) In situ hybridization. Decreased expression of <i>Pax2</i> mRNA at E12.5. …”
-
3710
-
3711
-
3712
-
3713
-
3714
Fig 6 -
Published 2021“…D) qPCR analysis of iNOS expression in C2C12 myotubes treated with 50 or 100 ng/mL TNF-α for 24 h. **** = <i>p</i><0.0001 indicate significantly decreased viability compared to the untreated control. …”
-
3715
-
3716
-
3717
-
3718
-
3719
-
3720